Obinutuzumab

Obinutuzumab is a medication used to treat certain types of blood cancers, like chronic lymphocytic leukemia (CLL) and some lymphomas. It is a type of targeted therapy known as a monoclonal antibody, which means it’s designed to attach specifically to cancer cells. By binding to these cells, obinutuzumab helps the immune system recognize and destroy them more effectively. This treatment can be administered alongside other therapies to improve outcomes for patients. While effective, it may have side effects, and its use is guided by a healthcare professional.